22 May 2013
Keywords: creative, biomolecules, op1, nears, end, testing, pivotal
Article | 22 May 1995
Pivotal trials of Creative Biomolecules' osteogenic protein (OP1), a
recombinant version of a natural compound which stimulates the formation
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 1995
15 May 1995
21 May 2013
© 2013 thepharmaletter.com